StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –

Novartis USD Growth in Rest of World by Quarter

USD Growth in Rest of World (% USD) (%)

QuarterlyAnnual

Novartis USD Growth in Rest of World: 14.0% in Q3 2026, down 8.0 pts from a year earlier.

Latest, Q3 2026
14.0%
Period ended Sep 30, 2026
Change on a year earlier
-8.0 pts
22.0% in Q3 2025
History
32 quarters
Since Q4 2018
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

“|| Ilaris | Immunology | Auto-inflammatory (CAPS, TRAPS, HIDS/MKD, FMF, SJIA, AOSD, gout) | 359 | 33 | 232 | 14 | 17 | 591 | 25 | 26”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUSD Growth in Rest of World (% USD) (%)Year on yearSource
Q3 2026Sep 30, 202614.0%-8.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20268.0%-17.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 202614.0%+8.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202522.0%+20.0 ptsNovartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 202522.0%+13.0 ptsNovartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202525.0%+11.0 ptsNovartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 20256.0%+4.0 ptsNovartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 20242.0%-27.0 ptsNovartis Form 6-K (0001370368-25-000007) ↗
Q3 2024Sep 30, 20249.0%-10.0 ptsNovartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202414.0%+4.0 ptsNovartis Form 6-K (0001370368-24-000019) ↗
Q1 2024Mar 31, 20242.0%-16.0 ptsNovartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202329.0%+31.0 ptsNovartis Form 6-K (0001370368-24-000007) ↗
Q3 2023Sep 30, 202319.0%+24.0 ptsNovartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202310.0%+6.0 ptsNovartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 202318.0%+11.0 ptsNovartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-2.0%-11.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗

Cite this data

StockData. (2026). Novartis USD Growth in Rest of World (%), quarterly Q4 2018–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/brand-ilaris-row-yoy-usd-pct

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.